Twenty-four-hour oesophageal pH monitoring of reflux episodes: effect of Algicon.
Devis
G
G
de Rop
H
H
Peters
O
O
D000328:Adult; D000464:Alginates / Q000627:therapeutic use*; D000536:Aluminum Hydroxide / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D002254:Carbonates / Q000627:therapeutic use*; D004942:Esophagitis, Peptic / Q000188:drug therapy / Q000503:physiopathology*; D004947:Esophagus / Q000187:drug effects / Q000503:physiopathology; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D002254:Carbonates; C060497:Algicon; D000536:Aluminum Hydroxide